MB
Manju Bist
About Manju Bist
Data last updated:
Manju Bist is a Director at Unosource Pharma Limited (since 2024), Director at Medibox Pharma Private Limited (since 2025) and Director at May And Baker Pharmaceuticals Limited (since 2009). The companies operate in Pharma, E-Commerce and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹173 Cr; the largest is Unosource Pharma Limited at ₹154 Cr (FY 2026). Earlier, Manju Bist was an Additional Director at Maxcure Nutravedics Limited (2006–2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unosource Pharma Limited U24233DL2013PLC262364 | Director | 20 Aug 2024 | 2013 | ₹154 Cr (FY 2026) | Active |
 Medibox Pharma Private Limited U72900DL2016PTC399490 | Director | 06 Feb 2025 | 2016 | ₹18.01 Cr (FY 2026) | Active |
 May And Baker Pharmaceuticals Limited U15400DL2006PLC145272 | Director | 02 Mar 2009 | 2006 | ₹1.22 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maxcure Nutravedics Limited U74899DL1994PLC057323 | Additional Director | 12 Aug 2006 | 1994 | ₹651 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manju Bist
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Saroha | Unosource Pharma Limited | Ceo | |
| Eti Vashist | Unosource Pharma Limited | Company Secretary | |
| Manmohan Singh | 02994045 | Unosource Pharma Limited | Director |
| Sanjay Chandrakant Chalke | 07679410 | Unosource Pharma Limited | Director |
| Sumeet Sood | Unosource Pharma Limited | Cfo | |
| Sumeet Sood | 06934358 | Unosource Pharma Limited | Cfo |
| Gopi Nath Sahu | 02877564 | Medibox Pharma Private Limited | Director |
| Pooja Sharma | 07185490 | May And Baker Pharmaceuticals Limited | Director |
| Ritu Mirg | 02583605 | May And Baker Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manju Bist
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manju Bist
Manju Bist currently holds 3 directorships: Unosource Pharma Limited (Director, since 20 Aug 2024, revenue ₹154 Cr (FY 2026)); Medibox Pharma Private Limited (Director, since 06 Feb 2025, revenue ₹18.01 Cr (FY 2026)); May And Baker Pharmaceuticals Limited (Director, since 02 Mar 2009, revenue ₹1.22 Cr (FY 2026)).
Manju Bist was first appointed on 12 Aug 2006 as Additional Director at Maxcure Nutravedics Limited. The most recent appointment on record is 06 Feb 2025 at Medibox Pharma Private Limited.
The 3 current companies of Manju Bist that report revenue have a combined latest revenue of ₹173 Cr: Unosource Pharma Limited ₹154 Cr (FY 2026); Medibox Pharma Private Limited ₹18.01 Cr (FY 2026); May And Baker Pharmaceuticals Limited ₹1.22 Cr (FY 2026).
Manju Bist held 1 earlier board appointment: Maxcure Nutravedics Limited (Additional Director, 12 Aug 2006 to 06 Mar 2009).
The current boards of Manju Bist's companies include Ashok Saroha (Unosource Pharma Limited), Eti Vashist (Unosource Pharma Limited), Manmohan Singh (Unosource Pharma Limited), Sanjay Chandrakant Chalke (Unosource Pharma Limited), Sumeet Sood (Unosource Pharma Limited), Sumeet Sood (Unosource Pharma Limited), among others.